Concepedia

Publication | Open Access

Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis

DOIFull Paper Access

239

Citations

32

References

2019

Year

Srikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, Hiroyuki Murai, Richard J. Barohn, Isabel Illa, Saiju Jacob, John Vissing, Ted M. Burns, John T. Kissel,
Muscle & Nerve

Abstract

These findings provide evidence for the long-term safety and sustained efficacy of eculizumab for refractory gMG. Muscle Nerve 2019.

References

YearCitations

Page 1